ICU Medical (NASDAQ:ICUI) Upgraded to “Hold” at StockNews.com

ICU Medical (NASDAQ:ICUI – Get Rating) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

A number of other brokerages have also recently issued reports on ICUI. Raymond James cut ICU Medical from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 8th. KeyCorp reduced their price objective on ICU Medical from $225.00 to $200.00 in a research note on Tuesday, November 8th.

ICU Medical Stock Down 2.3 %

Shares of NASDAQ:ICUI opened at $157.47 on Wednesday. The stock’s 50-day moving average price is $176.17 and its 200-day moving average price is $162.29. ICU Medical has a 12-month low of $128.90 and a 12-month high of $251.73. The stock has a market capitalization of $3.78 billion, a P/E ratio of -50.47 and a beta of 0.61. The company has a current ratio of 2.50, a quick ratio of 1.09 and a debt-to-equity ratio of 0.78.

Insider Buying and Selling

In related news, VP Daniel Woolson sold 1,731 shares of the firm’s stock in a transaction dated Thursday, February 2nd. The stock was sold at an average price of $200.00, for a total value of $346,200.00. Following the sale, the vice president now directly owns 9,152 shares of the company’s stock, valued at $1,830,400. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 7.30% of the stock is owned by insiders.

Institutional Trading of ICU Medical

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Covestor Ltd lifted its holdings in ICU Medical by 86.4% in the first quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 57 shares during the period. Captrust Financial Advisors lifted its holdings in ICU Medical by 4.5% in the second quarter. Captrust Financial Advisors now owns 1,327 shares of the medical instruments supplier’s stock worth $218,000 after buying an additional 57 shares during the period. Moody National Bank Trust Division lifted its holdings in ICU Medical by 1.2% in the fourth quarter. Moody National Bank Trust Division now owns 5,240 shares of the medical instruments supplier’s stock worth $825,000 after buying an additional 63 shares during the period. Yousif Capital Management LLC lifted its holdings in ICU Medical by 0.7% in the fourth quarter. Yousif Capital Management LLC now owns 10,366 shares of the medical instruments supplier’s stock worth $1,632,000 after buying an additional 67 shares during the period. Finally, Oregon Public Employees Retirement Fund lifted its holdings in ICU Medical by 1.2% in the third quarter. Oregon Public Employees Retirement Fund now owns 5,861 shares of the medical instruments supplier’s stock worth $883,000 after buying an additional 72 shares during the period. 93.88% of the stock is currently owned by hedge funds and other institutional investors.

About ICU Medical

(Get Rating)

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.